Stay updated on DETERMINE-preserved: Dapagliflozin Clinical Trial
Sign up to get notified when there's something new on the DETERMINE-preserved: Dapagliflozin Clinical Trial page.

Latest updates to the DETERMINE-preserved: Dapagliflozin Clinical Trial page
- Check2 days agoChange DetectedAdded a government funding notice banner at the top of the page and updated to revision v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check9 days agoChange DetectedAdded a glossary toggle display; updated footer labels with capitalization changes (Last Update Submitted that Met QC Criteria, No FEAR Act Data) and bumped the revision to v3.4.0.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check44 days agoChange DetectedLocations section updated to include multiple US states and Canadian provinces, with a new revision tag (v3.3.3).SummaryDifference1%

- Check73 days agoChange DetectedPubMed publication note wording updated to indicate automatic filling from PubMed and the revision label upgraded to v3.3.2; the previous PubMed note and version v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedRemoved the government funding status notice, which does not affect study content or data; the rest of the page content and location listings remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to DETERMINE-preserved: Dapagliflozin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DETERMINE-preserved: Dapagliflozin Clinical Trial page.